This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis

NCT07364487 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Due to the sponsor's adjustment of the research and development strategy for this clinical trial, this study was prematurely terminated, and no subjects were recruited for this study.

Conditions

Interventions

Sponsor

Huashan Hospital